This inventor holds 2 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignee: Glaxosmithkline Intellectual Property Development Limited. Active years: 2022-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022-2026
Title: Kenneth G. Yancey: Innovator in Antibody Purification
Introduction
Kenneth G. Yancey is a notable inventor based in Wayne, PA (US). He has made significant contributions to the field of biotechnology, particularly in the purification of antibodies. His innovative methods have the potential to enhance the efficiency of antibody production, which is crucial for various medical applications.
Latest Patents
Kenneth G. Yancey holds a patent for "Methods for purifying antibodies." This invention relates to a method of purifying a recombinant polypeptide from Host Cell Proteins (HCP). The method involves applying a solution containing the recombinant polypeptide and HCP to a superantigen chromatography solid support. It also includes washing the solid support with a wash buffer comprising caprylate and arginine, followed by eluting the recombinant polypeptide from the solid support. This patent showcases his expertise in developing advanced purification techniques.
Career Highlights
Kenneth G. Yancey is associated with GlaxoSmithKline Intellectual Property Development Limited, where he continues to work on innovative solutions in biotechnology. His career reflects a commitment to advancing scientific knowledge and improving healthcare outcomes through his inventions.
Collaborations
Throughout his career, Kenneth has collaborated with esteemed colleagues, including Andre C. Dumetz and Kent E. Goklen. These collaborations have likely contributed to the development of his innovative methods and have fostered a productive research environment.
Conclusion
Kenneth G. Yancey is a distinguished inventor whose work in antibody purification has the potential to impact the biotechnology industry significantly. His contributions reflect a dedication to innovation and excellence in scientific research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
